168 related articles for article (PubMed ID: 12825859)
1. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
Liby K; Neltner B; Mohamet L; Menchen L; Ben-Jonathan N
Breast Cancer Res Treat; 2003 May; 79(2):241-52. PubMed ID: 12825859
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer.
Nitze LM; Galsgaard ED; Din N; Lund VL; Rasmussen BB; Berchtold MW; Christensen L; Panina S
Breast Cancer Res Treat; 2013 Nov; 142(1):31-44. PubMed ID: 24146212
[TBL] [Abstract][Full Text] [Related]
3. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
4. Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer.
Bonneterre J; Peyrat JP; Beuscart R; Demaille A
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):977-81. PubMed ID: 2285609
[TBL] [Abstract][Full Text] [Related]
5. Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing.
Shaw-Bruha CM; Pirrucello SJ; Shull JD
Breast Cancer Res Treat; 1997 Jul; 44(3):243-53. PubMed ID: 9266104
[TBL] [Abstract][Full Text] [Related]
6. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
Rasmussen LM; Frederiksen KS; Din N; Galsgaard E; Christensen L; Berchtold MW; Panina S
Endocr Relat Cancer; 2010 Sep; 17(3):809-22. PubMed ID: 20601496
[TBL] [Abstract][Full Text] [Related]
9. Prolactin involvement in breast cancer.
Vonderhaar BK
Endocr Relat Cancer; 1999 Sep; 6(3):389-404. PubMed ID: 10516853
[TBL] [Abstract][Full Text] [Related]
10. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
11. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
12. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
13. 16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.
Faupel-Badger JM; Ginsburg E; Fleming JM; Susser L; Doucet T; Vonderhaar BK
Horm Cancer; 2010 Apr; 1(2):71-9. PubMed ID: 21113329
[TBL] [Abstract][Full Text] [Related]
14. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
[TBL] [Abstract][Full Text] [Related]
15. Prolactin as an autocrine/paracrine factor in breast tissue.
Clevenger CV; Plank TL
J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):59-68. PubMed ID: 10887520
[TBL] [Abstract][Full Text] [Related]
16. Prolactin receptor attenuation induces zinc pool redistribution through ZnT2 and decreases invasion in MDA-MB-453 breast cancer cells.
Bostanci Z; Alam S; Soybel DI; Kelleher SL
Exp Cell Res; 2014 Feb; 321(2):190-200. PubMed ID: 24333596
[TBL] [Abstract][Full Text] [Related]
17. Alpha
Castillo LF; Rivero EM; Goffin V; Lüthy IA
Cell Signal; 2017 Jun; 34():76-85. PubMed ID: 28302567
[TBL] [Abstract][Full Text] [Related]
18. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
19. Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54nrb-related mRNA in rat lymphoma cells.
Too CK; Knee R; Pinette AL; Li AW; Murphy PR
Mol Cell Endocrinol; 1998 Feb; 137(2):187-95. PubMed ID: 9605521
[TBL] [Abstract][Full Text] [Related]
20. Should prolactin be reconsidered as a therapeutic target in human breast cancer?
Goffin V; Touraine P; Pichard C; Bernichtein S; Kelly PA
Mol Cell Endocrinol; 1999 May; 151(1-2):79-87. PubMed ID: 10411322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
